Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.

Gary Cook, S. Houston, R.D. Rubens et al. · Journal of Clinical Oncology · 1998 · 563 citations

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.

Paul Shreve, H. Barton Grossman, Milton D. Gross et al. · Radiology · 1996 · 396 citations

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

Thierry Bury, Ana Terra Fonseca Barreto, Frédéric Daenen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1998 · 315 citations · Full text

Positron Emission Tomography, Bone Imaging, Engineering +12

Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy

Masateru Ohta, Yutaka Tokuda, Yasuhiro Suzuki et al. · Nuclear Medicine Communications · 2001 · 177 citations

Positron Emission Tomography, 99Tcm-mdp Bone Scintigraphy, Bone Imaging +12

Mechanisms of Lytic and Blastic Metastatic Disease of Bone

C. S. B. Galasko · Clinical Orthopaedics and Related Research · 1982 · 119 citations

Bone Disease, Blastic Metastatic Disease, Orthopaedic Surgery +12